Pharmacy- Page 14

Roche ranked the most sustainable healthcare company in the DJSI

November 16, 2020

Pharmacy

The FINANCIAL — For the eleventh time, Roche has been recognised as the most sustainable company in the Pharmaceuticals index of the Dow Jones Sustainability Indices (DJSI). This is based on an in-depth analysis of economic, social and environmental performance. The DJSI family of indices serves as a benchmark for investors who integrate sustainability considerations into their portfolios. Roche has

Gilead and Novo Nordisk announced new data from proof-of-concept trial in NASH

The FINANCIAL — Gilead Sciences, Inc. and Novo Nordisk A/S announced results

by The FINANCIAL

November 16, 2020

2 mins read

Metagenomi closes USD 65 million Series A financing led by Leaps by Bayer and Humboldt Fund

The FINANCIAL — Metagenomi, a next generation gene editing company launched by

by The FINANCIAL

November 12, 2020

1 min read

Pharmaceutical industries join to promise fair access to COVID-19 medicines and vaccines

The FINANCIAL — On the occasion of the World Health Assembly, the world’s

by The FINANCIAL

November 12, 2020

1 min read

Pharmacy

Lilly, CureVac In Global Collaboration To Develop MRNA Cancer Vaccines

The FINANCIAL -- Eli Lilly and Company and CureVac AG have announced a global immuno-oncology collaboration focused on the development and commercialization of up to five potential cancer vaccine products based on CureVac's proprietary RNActive technology.

by The FINANCIAL

October 18, 2017

1 min read

Pharmacy

Johnson & Johnson Reports 2017 Third-Quarter Results

The FINANCIAL -- Johnson & Johnson on October 17 announced sales of $19.7 billion for the third quarter of 2017, an increase of 10.3% as compared to the third quarter of 2016.

by The FINANCIAL

October 17, 2017

4 mins read

Pharmacy

Six-year Efficacy Data for GARDASIL 9 Presented at EUROGIN 2017 Congress

The FINANCIAL -- Merck, known as MSD outside of the United States and Canada, announced results from final analyses of the pivotal Phase III efficacy, immunogenicity, and safety clinical trial for GARDASIL 9 (Human Papillomavirus 9-valent Vaccine, Recombinant).

by The FINANCIAL

October 11, 2017

2 mins read

Pharmacy

Amgen : FDA Accepts SBLA For Prolia

The FINANCIAL -- Amgen on October 9 announced that the U.S. Food and Drug Administration (FDA) has accepted for review the supplemental Biologics License Application (sBLA) for Prolia (denosumab) for the treatment of patients with glucocorticoid-induced osteoporosis (GIOP).

by The FINANCIAL

October 10, 2017

6 mins read

Pharmacy

Bristol-Myers Squibb Appoints Saurabh Saha, M.D., Ph.D., as Senior Vice President, Global Head of Translational Medicine

The FINANCIAL -- Bristol-Myers Squibb Company announced that it has appointed scientific and business thought-leader, Saurabh Saha, M.D., Ph.D., as senior vice president and global head of translational medicine in the company’s R&D organization, effective October 9.

by The FINANCIAL

October 9, 2017

1 min read

Pharmacy

Appellate Court Orders a New Trial and Vacates Previous Judgments in Ongoing Patent Case Regarding Praluent

The FINANCIAL -- Sanofi and Regeneron Pharmaceuticals, Inc. on October 5 announced that the U.S. Court of Appeals for the Federal Circuit has ordered a new trial and vacated the permanent injunction in the dispute concerning Amgen’s asserted patent claims for antibodies

by The FINANCIAL

October 6, 2017

1 min read

Pharmacy

U.S. Patent and Trademark Office Rules In Lilly’s Favor On Alimta Vitamin Regimen Patent

The FINANCIAL -- Eli Lilly and Company on October 5 announced that the Patent Trial and Appeal Board of the U.S. Patent and Trademark Office (PTO) has ruled in the company's favor regarding patentability of the vitamin regimen for Alimta (pemetrexed for

by The FINANCIAL

October 6, 2017

1 min read

Pharmacy

Gilead Sciences Completes Tender Offer for All Outstanding Shares of Kite Pharma, Inc.

The FINANCIAL -- Gilead Sciences, Inc. on October 3 announced the successful completion of the tender offer by its wholly-owned subsidiary, Dodgers Merger Sub, Inc., for all of the outstanding shares of common stock of Kite Pharma, Inc. at a price of

by The FINANCIAL

October 3, 2017

1 min read

Pharmacy

Johnson & Johnson Announces Completion of Codman Neurosurgery Divestiture to Integra LifeSciences Holding Corporation

The FINANCIAL -- Johnson & Johnson on October 3 announced the completion of the divestiture of its Codman Neurosurgery business to Integra LifeSciences Holding Corporation for an approximate value of $1.045 billion, subject to customary adjustments.

by The FINANCIAL

October 3, 2017

1 min read

Pharmacy

Allergan: FDA To Review SNDA For AVYCAZ

The FINANCIAL -- Allergan plc on October 2 announced the U.S. Food and Drug Administration (FDA) has accepted a supplemental New Drug Application (sNDA) for AVYCAZ (ceftazidime and avibactam) for priority review.

by The FINANCIAL

October 2, 2017

4 mins read

Previous 1 … 12 13 14 15 16 … 195 Next

Pharmacy- Page 14

Roche ranked the most sustainable healthcare company in the DJSI

Gilead and Novo Nordisk announced new data from proof-of-concept trial in NASH

Metagenomi closes USD 65 million Series A financing led by Leaps by Bayer and Humboldt Fund

Pharmaceutical industries join to promise fair access to COVID-19 medicines and vaccines

Lilly, CureVac In Global Collaboration To Develop MRNA Cancer Vaccines

Johnson & Johnson Reports 2017 Third-Quarter Results

Six-year Efficacy Data for GARDASIL 9 Presented at EUROGIN 2017 Congress

Amgen : FDA Accepts SBLA For Prolia

Bristol-Myers Squibb Appoints Saurabh Saha, M.D., Ph.D., as Senior Vice President, Global Head of Translational Medicine

Appellate Court Orders a New Trial and Vacates Previous Judgments in Ongoing Patent Case Regarding Praluent

U.S. Patent and Trademark Office Rules In Lilly’s Favor On Alimta Vitamin Regimen Patent

Gilead Sciences Completes Tender Offer for All Outstanding Shares of Kite Pharma, Inc.

Johnson & Johnson Announces Completion of Codman Neurosurgery Divestiture to Integra LifeSciences Holding Corporation

Allergan: FDA To Review SNDA For AVYCAZ

Popular Posts

Natali Safaryan – The Voice of Armenia on the International Stage

We Are Proud of Every Jury Member”: Mykyta Harmel and the Global Mission of Golden Time Talent

By 41% to 30% public say government right to u-turn on welfare

Sean Combs Trial: A High-Profile Case Ends in Mixed Verdict, Exposing Prosecutorial Missteps

International Festival of Arts and Talents in London: World Talent Award 2025

Modern bathroom that you will be proud of having it

Artificial intelligence powers record-breaking all-in-one miniature spectrometers

Poverty rate in India was slashed, says report, but globally 1.2bn still poor

Food industry shows ‘stalled progress’ to reduce salt intakes

Depressed people are just more realistic, right? Not so, says UC Berkeley study

Recent Posts

Get updates

Join

Latest comments

Suggestions

Pharmacy- Page 14

Popular Posts

Recent Posts

Get updates

Join

Latest comments